Next-Gen Healing Starts Here
Unlock the power of exosomes! Refined over eleven years of research, derived from a single pre-COVID 2018 donation. and replicated through a patent-pending process. OmniGenix delivers unmatched purity in every vial. Experience the next generation of regenerative medicine that accelerates repair and recovery, free from the uncertainties of post-vaccination tissue.
See How OmniGenix Compares
The chart below highlights what rigorous testing makes clear: our exosome platform delivers superior biological performance compared to competing products in the United States. Across critical metrics, including concentration, purity, and functional signaling. Our formulation dominates the market.
| Assay / Metric | Brand A | Brand B | Brand C | Brand D | Brand E |  |
|---|---|---|---|---|---|---|
| Volume per Vial (mL) | 5 | 5 | 5 | 5 | 3 | 5 |
| Concentration & Potency | ||||||
| Protein Concentration (ug/mL) BCA — ID5 Plate Reader, Molecular Device |
557.4 | 480.4 | 96.5 | 103.9 | 287.3 | 1,672 3× Higher |
| Exosome Concentration (ug/mL) SEC-HPLC — Agilent Technologies |
1.6 | 1.9 | 1.7 | 175.1 92× Higher | ||
| RNA Content | ||||||
| RNA Concentration (ug/mL) Quantitative Fluorescence — Qubit, Invitrogen |
56.4 Only Detectable | |||||
| RNA Concentration (ug/mL) Quantitative Fluorescence — ID5, Molecular Device |
1.9 | 1.9 | 1.6 | 1.7 | 1.6 | 56.8 30× Higher |
| Exosome Identity Biomarkers | ||||||
| CD81 Surface Biomarker Western Blot — ID5, Molecular Device |
Yes | Yes | Yes ✓ | |||
| CD63 Surface Biomarker Western Blot — iBlot, Invitrogen System |
Yes ✓ Only One | |||||
| Biological Activity | ||||||
| Biological Active Units (BAU) Potency / functional bioactivity measure |
0.5 | 0 | 3 | 2 | 496 165× Higher | |
A product can never outperform the quality of its source material and the process used to create it.
Marketing doesn't change biology, although testing reveals it.
ND (None Detected) doesn't mean low quality — it means the markers simply aren't there. If the defining biological markers are absent, calling it an Exosome is a marketing decision. Not a scientific one.
Pharmaceutical-Grade Precision.
Uncompromising Purity.
OmniGenix delivers the most rigorously tested, precisely characterized MSC-derived exosomes available today. Every vial originates from a single, pre-COVID placental line — replicated through a patent-pending process that guarantees consistent potency without ever requiring a new donor.
Manufactured in ISO 7 clean rooms using xeno-free media, verified by dSTORM super-resolution microscopy, and quarantined until independently cleared — this is regenerative medicine held to a standard the industry has never seen.
Five Pillars of the OmniGenix Difference
Pre-COVID Purity
Sourced from a single 2018 placental donation — guaranteed 100% free of spike proteins and vaccine byproducts. Forever.
Patent-Pending Process
Our proprietary replication method produces consistent, pharmaceutical-grade exosomes from a single verified line — in perpetuity.
cGMP Manufacturing
Produced in a 27,000 sq ft FDA-inspected facility with ISO 7 clean rooms and ISO 5 laminar flow isolators.
Batch-Level Testing
Every lot quarantined and independently verified for sterility, potency, endotoxins, and pathogen absence before release.
100× More RNA
Verified via RT-PCR and Illumina NextSeq 1000 sequencing — delivering more regenerative intelligence per dose than any competitor.
Advanced Regenerative Solutions
Three precision-engineered product lines — each rigorously tested, GMP manufactured, and backed by Certificate of Analysis documentation.
Exosomes
Placenta-derived, precisely characterized nano-vesicles engineered for targeted regeneration and systemic optimization.
Stem Cells
Ethically sourced, rigorously tested solutions designed for precision regenerative protocols across multiple clinical applications.
Peptides
A curated catalog of research-grade peptides supporting therapeutic and performance-optimization applications.
Getting Started Is Simple
Free Consultation
Connect with an OmniGenix specialist to discuss your practice goals, patient needs, and explore the right product fit.
Onboarding
Our team walks you through protocols, clinical education, and everything you need to confidently integrate OmniGenix into your practice.
Portal Access & Pricing
Get full access to our practitioner portal with transparent product pricing, order management, and dedicated support.
Trusted by Practitioners. Proven in Practice.
Within two weeks of integrating OmniGenix MSC-exosomes, postoperative swelling plummeted and rehab milestones arrived sooner. Patients stood, walked, and smiled ahead of schedule. This technology redefines orthopedic recovery.
After relentless tendon pain sidelined me for years, a single OmniGenix exosome treatment changed everything. Within days, inflammation subsided. Weeks later I was back conquering Colorado's peaks with confidence.
OmniGenix's transparent data, GMP-grade consistency, and immersive training empowered our team to adopt regenerative care with confidence. We've seen faster recoveries and a 40% surge in referrals.
Invest in Tomorrow's Medicine — Starting Today
Join the growing network of forward-thinking practitioners and patients who are redefining what's possible with regenerative cellular therapy.
Join the Regenerative Revolution
We invite you to delve deeper into the transformative world of exosome therapies. Engage with our resources, ask questions, and discover how OmniGenix can enhance your health journey.
Discover Our Core Advantages
Unmatched Purity
Our exosomes are sourced from a single, exclusive placenta-derived line, ensuring unparalleled purity and consistency in every batch.
Advanced Research
Backed by over eleven years of dedicated research, our products are at the forefront of regenerative medicine.
FDA Compliance
We offer the only exosome therapies with IND approval for research and investigational use, ensuring safety and compliance.
Innovative Technology
Utilizing cutting-edge technology, our exosomes are designed to optimize cellular communication and regeneration.
